Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aprotinin dosing: how much is enough?

Kevin S Niimi1

  • 1St. Louis Children's Hospital, Perfusion Department, One Children's Place, St. Louis, MO 63110, USA. kxn5637@bjc.org

The Journal of Extra-Corporeal Technology
|February 1, 2005
PubMed
Summary
This summary is machine-generated.

Aprotinin effectively reduces bleeding and transfusions in cardiac surgery. Weight-based dosing may optimize aprotinin (a serine protease inhibitor) benefits while minimizing costs and potential overdose.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impairment of Venous Drainage on Extracorporeal Membrane Oxygenation Secondary to Air Trapping in Acute Asphyxial Asthma.

The journal of extra-corporeal technology·2015
Same author

Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.

The journal of extra-corporeal technology·2014
Same author

Construction of a pulmonary artery pump for unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals.

Perfusion·2005
See all related articles

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology
  • Hemostasis

Background:

  • Postoperative bleeding is a significant complication in cardiac surgery with cardiopulmonary bypass.
  • Pharmacologic interventions to mitigate bleeding are of high clinical interest.
  • Aprotinin, a serine protease inhibitor, has demonstrated efficacy in reducing blood loss and transfusion requirements.

Purpose of the Study:

  • To review the effectiveness of various aprotinin dosing strategies.
  • To examine the potential benefits of a weight-based aprotinin dosing regimen.
  • To identify optimal aprotinin administration for maximal efficacy and cost-effectiveness.

Main Methods:

  • Review of existing studies on aprotinin dosing regimens.
  • Analysis of aprotinin's effectiveness in reducing bleeding and transfusion needs.
  • Evaluation of weight-based dosing versus standard regimens.

Main Results:

  • Aprotinin is effective in reducing bleeding and the need for blood components post-cardiac surgery.
  • Various dosing regimens have yielded differing results regarding efficacy.
  • Weight-based dosing may offer advantages in optimizing therapeutic benefits and avoiding excessive administration.

Conclusions:

  • Optimizing aprotinin dosage is crucial for managing bleeding in cardiac surgery.
  • Weight-based dosing presents a potential strategy to maximize aprotinin's benefits while controlling costs.
  • Further research into specific weight-based regimens is warranted to confirm optimal clinical application.